“Clinical Reach is positively disrupting how clinical trials are being run,” said David Turner President, CTO, and Founder of Parallel 6
San Diego, California (PRWEB) September 09, 2015
Parallel 6, an innovator in enterprise mobile engagement and management solutions, was chosen as one of only five companies to participate in DPharm Idol at the 5th annual DPharm: Disruptive Innovations to Advance Clinical Trials Conference in Boston, MA. Its President, CTO, and Founder, David Turner, will pitch their patented platform, Clinical Reach, to a panel of industry judges, proving how its end-to-end patient engagement platform is innovating within the clinical trial space and why they are worthy of the DPharm Idol title.
Clinical Reach is powering multiple clinical trials in 2015. The enterprise platform is helping some of the industry’s top Biopharma, Institutes and other stakeholders to more efficiently enroll and quickly connect with participants when and where it matters most, in the palm of the participant’s hand.
“Clinical Reach is positively disrupting how clinical trials are being run,” said Turner. “Its ability to eQualify, eConsent and engage clinical trial participants in real-time via a participants Internet enabled device is changing how clinical trial providers interact with their stakeholders around the world, and we can’t wait to show the panel of judges what our patented technology can accomplish.”
DPharm idol will take place on September 10 at 5 pm EST. One presenter will be chosen and take the title as the most disruptive company of the year. Past Dpharm idol winners include ePharmaSolutions, Medidata Solutions and Spaulding Clinical Research.
Turner and his team will be available for interviews and demos of Parallel 6’s technology platform September 10-11 at Dpharm booth 23. To schedule, please contact Aimee Eucce at aeucce(AT)parallel6.com. To stay connected during the event, follow @ClinicalReach.
About Parallel 6
Parallel 6, an innovator in enterprise cloud-based technologies which enables customer engagement, and real-time data insights. Clinical Reach, a Parallel 6 product, enables clinical trial stakeholders to digitally recruit, eQualify, eConsent and engage clinical trial participants through their patented platform. Additional solutions include GovReach for Government Agencies and Captive Reach for corporate organizations which desire to communicate via push notifications, gamification strategies and more. The firm is headquartered in San Diego with Federal offices in Washington D.C. For more information, visit http://www.parallel6.com/.